Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1883691 | 1.00 | TK1 (0.55) | TK1 | |
| SCHEMBL7908347 | 0.93 | TK1 (0.51) | TK1 | |
| Doxribtimine SCHEMBL8640450 | 0.84 | TK1 (0.53) | TK1 | |
| SCHEMBL10446716 | 0.82 | POLB (0.58) | TK1 | |
| SCHEMBL6334503 | 0.82 | POLB (0.58) | TK1 | |
| SCHEMBL1727320 | 0.82 | POLB (0.58) | TK1 | |
| SCHEMBL8655889 | 0.82 | DUT (0.71) | — | |
| SCHEMBL1727537 | 0.82 | POLB (0.58) | TK1 | |
| SCHEMBL8655891 | 0.82 | DUT (0.71) | — | |
| SCHEMBL6077816 | 0.82 | POLB (0.58) | TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2952587-B1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS INC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-20180334729-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | Roche Sequencing Solutions, Inc. | 2018-11-22 | — | — | US | disclosed |
| US-9920386-B2 | High throughput nucleic acid sequencing by expansion | STRATOS GENOMICS, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-20160208344-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | Roche Sequencing Solutions, Inc. | 2016-07-21 | — | — | US | disclosed |
| EP-2952587-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | Stratos Genomics Inc. (US) | 2015-12-09 | — | — | EP | disclosed |
| EP-2171088-B1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS INC (US) | 2015-10-14 | — | — | EP | disclosed |
| US-20130172197-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| US-8349565-B2 | High throughput nucleic acid sequencing by expansion | STRATOS GENOMICS, INC. (US) | 2013-01-08 | — | — | US | disclosed |
| US-8324360-B2 | High throughput nucleic acid sequencing by expansion | STRATOS GENOMICS, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| US-20110251079-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS, INC. (US) | 2011-10-13 | — | — | US | disclosed |
| WO-2008157696-A2 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | STRATOS GENOMICS INC. (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20060040282-A1 | Oligonucleotide sizing using cleavable primers | SEQUENOM, INC. (US) | 2006-02-23 | — | — | US | disclosed |
| US-6949633-B1 | Primers useful for sizing nucleic acids | SEQUENOM, INC. (US) | 2005-09-27 | — | — | US | disclosed |
| EP-0828855-B1 | Oligonucleotide sizing using cleavable primers | STANFORD RES INST INT (US) | 1999-12-15 | — | — | EP | disclosed |
| US-5830655-A | DETERMINATION THE SIZE OF PRIMER EXTENSION | SRI INTERNATIONAL (US) | 1998-11-03 | — | — | US | disclosed |
| US-5807837-A | ADMINISTERING TO TREAT HIV INFECTIONS TO INHIBIT THE REPLICATION OF FOREIGN NUCLEIC ACIDS IN A NORMAL CELL | SANKYO COMPANY, LIMITED (JP) | 1998-09-15 | — | — | US | disclosed |
| EP-0828855-A1 | OLIGONUCLEOTIDE SIZING USING CLEAVABLE PRIMERS | SRI INTERNATIONAL (US) | 1998-03-18 | — | — | EP | disclosed |
| US-5700642-A | HYBRIDIZING PRIMER WITH COMPLEMENTARY TARGET NUCLEIC ACID, ENZYMATICALLY EXTENDING PRIMER TO GENERATE POLYNUCLEOTIDE MIXTURE, IMMOBILIZATION, CLEAVING TO RELEASE EXTENSION SEGMENT AND MEASUREMENT BY MASS SPECTROMETRY | SRI INTERNATIONAL (US) | 1997-12-23 | — | — | US | disclosed |
| US-5674856-A | TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS, INCLUDING AIDS AND TUMORS | SANKYO COMPANY, LIMITED (JP) | 1997-10-07 | — | — | US | disclosed |
| WO-1996037630-A1 | OLIGONUCLEOTIDE SIZING USING CLEAVABLE PRIMERS | SRI INTERNATIONAL (US) | 1996-11-28 | — | — | WO | disclosed |